دورية أكاديمية

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation

التفاصيل البيبلوغرافية
العنوان: Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
المؤلفون: Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
المساهمون: National Institute for Health Research
المصدر: Kidney International Reports ; volume 6, issue 1, page 224-227 ; ISSN 2468-0249
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Nephrology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.ekir.2020.10.012
الإتاحة: https://doi.org/10.1016/j.ekir.2020.10.012Test
https://api.elsevier.com/content/article/PII:S2468024920316508?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2468024920316508?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.CF804992
قاعدة البيانات: BASE